Steroid pellet implants

Recombinant vaccines, such as those used against HBV and HPV, are made using a gene from the (disease-causing) pathogen. The gene is inserted into a cell system capable of producing large amounts of the protein of interest. The protein produced is capable of generating a protective immune response. For example, the gene for the hepatitis B surface antigen (HBsAg) is inserted into yeast cells, which replicate and produce large amounts of HBsAg. This is purified and used to make vaccine. The advantage of this approach is that it results in a very pure vaccine that is efficient to produce.

Abatacept (Orencia ® )  
Ado-Trastuzumab Emtansine (Trastuzumab-DM1) for Treatment of HER-2 Positive Malignancies
Alemtuzumab (Lemtrada TM )
Antiemetic Injection Therapy
Atezolizumab (Tecentriq) for Intravenous Use
Belimumab (Benlysta)
Bevacizumab in Advanced Adenocarcinoma of the Pancreas
Botulinum Toxin Injection
Brentuximab Vedotin (Adcetris)
Cabazitaxel (Jevtana)
Carfilzomib (Kyprolis ® )
CAR-T Therapy
Chemotherapy For Malignant Disease
Daratumumab (Darzalex)
Denosumab (Prolia TM , XGEVA TM )
Eculizumab (Soliris ® )
Edaravone (Radicava TM )
Elotuzumab (Empliciti)
Enzyme Replacement Therapy for Lysosomal Storage Disorders
Eribulin Mesylate (Halaven)
Erythropoiesis-Stimulating Agents (ESAs)
Eteplirsen for Duchenne Muscular Dystrophy
Golimumab (Simponi Aria)
Goserelin Acetate (Zoladex)
Immunoglobulin Therapy
Infliximab (Remicade)
Inotuzumab (Besponsa)
Interleukin-5 Antagonists
Intravenous Antiobiotic Therapy for Lyme Disease
Ipilimumab (Yervoy)
Melphalan Hydrochloride (Evomela) for Intravenous Use
Monoclonal Antibodies for Non-Hodgkin Lymphoma and Acute Myeloid Leukemia In the Non-Hematopoietic Stem Cell Transplant Setting
Natalizumab Tysabri
New-To-Market Specialty Drug PPA Requirements
Nusinersen (Spinraza TM )

Steroid pellet implants

steroid pellet implants


steroid pellet implantssteroid pellet implantssteroid pellet implantssteroid pellet implants